Circulation
Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT: A Prespecified Secondary Analysis
By Jorge Plutzky, Paweł Bogdański, Helen Martina Colhoun, Show 16 more authorsAbraham Michael Lincoff
Randomised trial in 17,604 peopleInterventions
39.8 months, placebo-controlled, registered NCT03574597, declared ties to: Altimmune, Amgen, Boehringer Ingelheim and 64 more
The paper
Brigham and Women's Hospital; Cleveland Clinic
Circulation, 18 Aug 2026
